Lowers costs and removes hurdles for Medicare Part D users to get non-opioid pain relief.
This bill would make it easier and cheaper for people on Medicare Part D to get certain non-opioid pain medications. Starting in 2026, these drugs would cost less out-of-pocket and would not require prior approval or trying opioids first. This aims to improve access to pain relief without relying on opioids.
Currently, Medicare Part D plans can make people pay a deductible, put non-opioid pain drugs on higher cost tiers, and require prior approval or trying opioids first. If this bill passes, starting January 1, 2026, qualifying non-opioid pain drugs would have no deductible, be on the lowest cost tier, and would not require prior approval or trying opioids first.
S 475 · 119th Congress · February 6, 2025 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers
20 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.